медицински науки и здравеопазване
7302 проекта
клинична медицина3770фундаментална медицина3735здравни науки1873медицинска биотехнология1182други медицински науки18
FP7Индивидуална стипендия2014–2016Австрия
QUMOCA · Quantitative Modeling of Calcium Signaling in Vascular Smooth Muscle Nanojunctions
FP7Индивидуална стипендия2014–2016Испания
DNAMETHYLOOPMCL · Of DNA methylation and looping of distant regulatory elements in mantle cell lymphoma
FP7Реинтеграция2014–2017Испания
NEUTANDALUS · boosting interdisciplinary neutron science in Spain and Europe
FP7Реинтеграция2014–2017Швейцария
X-TALK · Investigation of the cross-talk between innate and adaptive immunity
FP7Индивидуална стипендия2014–2016Обединеното кралство
"RTILS-GELS"""" · Novel Delivery Platform for Hydrophobic Drugs
FP7Реинтеграция2013–2017Испания
COLONGEVA · Implications of copy number variants of the genome in the etiology and progression of colorectal cancer
FP7Реинтеграция2013–2017Испания
RUDEFOPOS-IRAQ · Rural Development, Food Security and Political Stability in Iraq""
FP7Реинтеграция2013–2017Израел
Homomers · Exploiting homomers to reveal new principles of protein interaction, polymerization and aggregation
FP7Индивидуална стипендия2013–2016Испания
LYMFOXP1 · ROLE OF THE TRANSCRIPTION FACTOR FOXP1 IN B CELL FUNCTION AND LYMPHOMAGENESIS
FP7Реинтеграция2013–2017Германия
INFLACOMM · Interplay of inflammasomes, commensals and pathogens at mucosal interfaces
FP7Реинтеграция2013–2017Испания
KRASMIR · The role of miRNAs in KRAS-driven Non-Small Cell Lung Cancer
FP7Реинтеграция2013–2017Испания
MIRNATHERAPYNBL · New epigenetic therapy for high-risk neuroblastoma
FP7Реинтеграция2013–2017Израел
6-SENSE · The role of NLRP6 sensing in regulation of intestinal host-microbiome interactions
FP7Реинтеграция2013–2017Турция
MPI-ANGIO · Magnetic Particle Imaging for Safe Angiography
FP7Реинтеграция2013–2017Франция
PEPTHIV · Host defence peptides from neuroendocrine cells as a new source of anti-HIV compounds
FP7Реинтеграция2013–2017Обединеното кралство
LIVERNCODE · Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer
2 партньори
FP7Реинтеграция2013–2017Турция
TRIGBM · Identification of TRAIL sensitivity/resistance mechanisms and searching for novel TRAIL-sensitizing agents in Glioblastoma Multiforme
FP7Реинтеграция2013–2017Нидерландия
BLADDER CANCER EPID · Nutrition and Bladder Cancer
FP7Реинтеграция2013–2017Испания
ANTES · Accelerating Neuromuscular Treatment Selection
FP7Реинтеграция2013–2017Белгия
METABOLISMCONNECT · Can metabolic states induced by diabetes and obesity promote cancer?
FP7Обмен на изследователи2013–2017Испания
AIDPATH · Academia and Industry Collaboration for Digital Pathology
11 партньори · 8 държави
FP7Реинтеграция2013–2017Германия
FISHTIO2 · TITANIUM DIOXIDE – THE SILENT KILLER: FINDING THE RELEVANT BIOLOGICAL TARGET FOR EXPOSURE CHARACTERIZATION AND RISK ASSESSMENT OF NANOPARTICLES TOXICITY IN FISH MODEL
FP7Обмен на изследователи2013–2017Ирландия
CODEMISUSED · Codeine Use, Misuse and Dependence
6 партньори · 3 държави
FP7Реинтеграция2013–2017Израел